Monitoring of Symptoms and Cognitive Function Using Telehealth

Completed · Not applicable

Conditions studied: End Stage Liver Disease

In brief

End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor quality of life, mental deterioration and repeated hospitalizations. The overall purpose of this project is to introduce a telehealth based intervention (involving remote monitoring of symptoms and cognitive function initiated at the time of discharge of ESLD patients. This will support enhanced clinical care and improve self-management in ESLD population. In addition, it will reduce healthcare utilization, improve medication adherence and overall health outcomes

Key facts

Study ID

NCT03184701

Run by

Albert Einstein Healthcare Network

People needed

45

Starts

2016-04-30

Expected to finish

2018-08-30

Last updated by the study team

2020-04-17

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• End Stage Liver Disease with at least 1 or more complications (Hepatorenal Syndrome, Portal Hypertension, Ascites, Hepatic Encephalopathy)

You may not qualify if…

• Cognitive impairment
• Current psychosis

Where it is running

• Einstein Healthcare Network — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.